Cargando…
High-dose atorvastatin pretreatment could diminishes microvascular impairment in patients undergoing elective percutaneous coronary intervention
OBJECTIVES: High-dose statins pretreatment is reasonable before percutaneous coronary intervention (PCI) to reduce the risk of periprocedural myocardial injury. However, the mechanism underlying this protective effect has not been elucidated. The aim of this study is to evaluate the effects of high-...
Autores principales: | He, Gui-Xin, Tan, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888918/ https://www.ncbi.nlm.nih.gov/pubmed/24454329 http://dx.doi.org/10.3969/j.issn.1671-5411.2013.04.013 |
Ejemplares similares
-
Does Pre-Treatment with High Dose Atorvastatin Prevent Microvascular Dysfunction after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome?
por: Lee, Bong-Ki, et al.
Publicado: (2016) -
Effects of High-dose Atorvastatin Pretreatment in Patients with ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Cardiac Magnetic Resonance Study
por: Kim, Eun Kyoung, et al.
Publicado: (2015) -
Eptifibatide Bolus Dose During Elective Percutaneous Coronary Intervention
por: Doustkami, Hossein, et al.
Publicado: (2018) -
High-dose atorvastatin reduces the risk of cardiovascular events in patients with percutaneous coronary intervention
por: Lu, Changqing, et al.
Publicado: (2017) -
Effect of Pretreatment with Omega-3 Supplement on Cardiac Necrosis Markers in Chronic Kidney Disease Patients Undergoing Elective Percutaneous Coronary Intervention
por: Foroughinia, Farzaneh, et al.
Publicado: (2017)